Korea United Pharm Inc. (KRX:033270)

South Korea flag South Korea · Delayed Price · Currency is KRW
20,050
-100 (-0.50%)
Last updated: Feb 27, 2026, 3:00 PM KST
-0.74%
Market Cap 294.99B
Revenue (ttm) 161.44B
Net Income (ttm) 20.02B
Shares Out 14.71M
EPS (ttm) 1,260.76
PE Ratio 15.90
Forward PE 7.35
Dividend 450.00 (2.24%)
Ex-Dividend Date Dec 29, 2025
Volume 35,340
Average Volume 36,790
Open 20,150
Previous Close 20,150
Day's Range 19,800 - 20,250
52-Week Range 18,080 - 22,450
Beta 0.46
RSI 55.05
Earnings Date Feb 27, 2026

About Korea United Pharm

Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1987
Employees 665
Stock Exchange Korea Stock Exchange
Ticker Symbol 033270
Full Company Profile

Financial Performance

In 2014, Korea United Pharm's revenue was 155.19 billion, an increase of 13.37% compared to the previous year's 136.89 billion. Earnings were 18.37 billion, an increase of 50.46%.

Financial Statements

News

There is no news available yet.